The launch of a 750mcg PTH injection in Australia has been relatively limited , with access primarily via specialist physicians and designated clinics . Initial distribution numbers for this higher dosage remain confidential from the supplier , although reports suggest controlled adoption uptake levels . Availability to patients is dictated by the